Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-25T06:50:46.169Z Has data issue: false hasContentIssue false
  • English
  • Français

Changes in Schizophrenic Psychopathology and Ward Behaviour as a Function of Phenothiazine Treatment

Published online by Cambridge University Press:  29 January 2018

Solomon C. Goldberg ,
Gerald L. Klerman  and
Jonathan O. Cole
Solomon C. Goldberg
Affiliation:
Psychopharmacology Service Center, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland
Gerald L. Klerman
Affiliation:
Massachusetts Mental Health Center, and Harvard Medical School. Address: 74 Fenwood Road, Boston 15, Massachusetts
Jonathan O. Cole
Affiliation:
Psychopharmacology Service Center, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland
Get access Rights & Permissions [Opens in a new window]

Extract

Although the efficacy of chlorpromazine and other phenothiazine derivatives in the treatment of schizophrenic psychotic reactions has been established for almost a decade, there remain differences of opinion regarding which symptoms and behaviours are affected favourably by psychopharmacologic treatment. By and large, the phenothiazines have been characterized as “ataractics” or “tranquillizers”, the implication being that their predominant action is to calm excited patients by relieving the patient's anxiety or other forms of psychic distress. However, clinical experience increasingly asserts that the phenothiazines influence many manifestations of schizophrenic patients other than anxiety and excitement, including symptoms such as incoherent thought and apathy.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 111 , Issue 471 , February 1965 , pp. 120 - 133
Copyright
Copyright © Royal College of Psychiatrists, 1965 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Adelson, D., and Epstein, L. J. (1962). “A study of phenothiazines with male and female chronically ill schizophrenic patients.” J. Nerv. Merit. Dis., 134, 543–554.Google Scholar
2. Bleuler, E. (1911). Dementia Praecox or the Group of Schizophrenias (trans. Zinkin, Joseph, 1950). New York, N.Y.: International Universities Press.Google Scholar
3. Burdock, E. I., Hakerem, G., Hardesty, Anne S., and Zubin, J. (1959). Ward Behavior Rating Scale.CrossRefGoogle Scholar
4. Goldberg, S. C., Cole, J. O., and Clyde, D. J. (1963). “Factor analyses of ratings of schizophrenic behavior.” Psychopharmacology Service Center Bulletin, 2, 23–28.Google Scholar
5. Gross, M., Hitchman, Irene, Reeves, W. D., Lawrence, J., and Newell, P. (1960). “Discontinuation of treatment with ataractic drugs.” Amer. J. Psychiat., 116, 931–932.CrossRefGoogle Scholar
6. Katz, M. M., and Cole, J. O. (1963). “A phenomenological approach to the classification of schizophrenic disorders.” Dis. Nerv. Syst., 24, 1–8.Google Scholar
7. Krantz, J. C., Jr., and Carr, C. J. (1961). Pharmacologic Principles of Medical Practice. 5th edition. Baltimore, Md.: Williams and Wilkins.Google Scholar
8. Kurland, A. A., Hanlon, T. E., Tatom, Mary H., Ota, Kay Y., and Simopoulos, A. M. (1961). “The comparative effectiveness of six phenothiazine compounds, phenobarbital and inert placebo in the treatment of acutely ill patients: global measures of severity of illness.” J. Nerv. Ment. Dis., 133, 1–18.Google Scholar
9. Lasky, J. J., Klett, C. J., Caffey, E. M., Bennett, J. L., Rosenblum, M. P., and Hollister, L. E. (1962). “Drug treatment of schizophrenic patients: a comparative evaluation of chlorpromazine, chlorprothixene, fluphenazine, reserpine, thioridazine and triflupromazine.” Dis. Nerv. Syst., 23, 1–8.Google Scholar
10. Lorr, M., Klett, C. J., McNair, D. M., and Lasky, J. J. (1962). Inpatient Multi-Dimensional Psychiatric Scale (IMPS) Manual. Copyright: Maurice Lorr.Google Scholar
11. NIMH-PSC Collaborative Study Group (1964). “Phenothiazine treatment in acute schizophrenia.” Arch. Gen. Psychiat., 10, 246–261.Google Scholar
12. Overall, J. E., and Gorham, D. R. (1962). “The brief psychiatric rating scale.” Psychological Reports, 10, 799–812.Google Scholar
13. Oradell, N. J. (1963). Physicians' Desk Reference to Pharmaceutical Specialities and Biologicals. 17th edition. Medical Economics, Inc. Google Scholar
14. Schachter, S., and Singer, J. E. (1962). “Cognitive, social and physiological determinants of emotional state.” Psychol. Rev., 69, 379–397.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.